Literature DB >> 15251280

Mannose-binding quinone glycoside, MBQ: potential utility and action mechanism.

Yasuhiro Igarashi1, Toshikazu Oki.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15251280     DOI: 10.1016/S0065-2164(04)54006-6

Source DB:  PubMed          Journal:  Adv Appl Microbiol        ISSN: 0065-2164            Impact factor:   5.086


× No keyword cloud information.
  4 in total

1.  Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virus.

Authors:  Jan Balzarini; Kristel Van Laethem; Dirk Daelemans; Sigrid Hatse; Antonella Bugatti; Marco Rusnati; Yasuhiro Igarashi; Toshikazu Oki; Dominique Schols
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

2.  The alpha(1,2)-mannosidase I inhibitor 1-deoxymannojirimycin potentiates the antiviral activity of carbohydrate-binding agents against wild-type and mutant HIV-1 strains containing glycan deletions in gp120.

Authors:  Jan Balzarini
Journal:  FEBS Lett       Date:  2007-04-25       Impact factor: 4.124

3.  The carbohydrate-binding plant lectins and the non-peptidic antibiotic pradimicin A target the glycans of the coronavirus envelope glycoproteins.

Authors:  F J U M van der Meer; C A M de Haan; N M P Schuurman; B J Haijema; M H Verheije; B J Bosch; J Balzarini; H F Egberink
Journal:  J Antimicrob Chemother       Date:  2007-08-18       Impact factor: 5.790

4.  Antiviral activity of carbohydrate-binding agents against Nidovirales in cell culture.

Authors:  F J U M van der Meer; C A M de Haan; N M P Schuurman; B J Haijema; W J Peumans; E J M Van Damme; P L Delputte; J Balzarini; H F Egberink
Journal:  Antiviral Res       Date:  2007-05-21       Impact factor: 5.970

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.